COM:ADAPTIMMUNE

Adaptimmune Therapeutics plc

Stock

USD

Last Close

0.64

22/11 21:00

Market Cap

293.91M

Beta: -

Volume Today

1.34M

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Jun '14	Jun '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue			14.20M -	37.83M 166.47%	59.51M 57.28%	1.12M 98.11%	3.96M 252.76%	6.15M 55.36%	27.15M 341.50%	60.51M 122.91%
cost of revenue										9.86M -
gross profit			14.20M -	37.83M 166.47%	59.51M 57.28%	1.12M 98.11%	3.96M 252.76%	6.15M 55.36%	27.15M 341.50%	50.66M 86.60%
selling and marketing expenses										-25.99M -
general and administrative expenses			23.21M -	31.11M 34.03%	43.60M 40.17%	43.39M 0.48%	45.80M 5.54%	57.30M 25.13%	63.39M 10.61%	71.81M 13.29%
selling general and administrative expenses			23.21M -	31.11M 34.03%	43.60M 40.17%	43.39M 0.48%	45.80M 5.54%	57.30M 25.13%	63.39M 10.61%	45.82M 27.71%
research and development expenses			63.79M -	87.39M 37.00%	98.27M 12.45%	97.50M 0.78%	91.57M 6.09%	111.09M 21.32%	127.73M 14.98%	142.60M 11.65%
other expenses	-281.02K -	-726.50K 158.52%	1.00M 237.92%	8.74M 772.65%	-15.50M 277.28%	75K 100.48%	1.16M 1,449.33%	3.85M 231.50%	-536K 113.91%	-807K 50.56%
cost and expenses			87.00M -	118.49M 36.20%	141.87M 19.73%	140.89M 0.69%	137.36M 2.50%	168.40M 22.59%	191.11M 13.49%	198.28M 3.75%
operating expenses	14.98M -	33.79M 125.63%	87.00M 157.46%	118.49M 36.20%	141.87M 19.73%	140.89M 0.69%	137.36M 2.50%	168.40M 22.59%	191.11M 13.49%	188.42M 1.41%
interest expense		-508.24K -		2.23M -	376K 83.14%				-1.01M -
ebitda			-69.51M -	-75.24M 8.24%	-74.56M 0.91%	-131.76M 76.73%	-125.81M 4.52%	-155.68M 23.74%	-157.89M 1.42%	-127.91M 18.99%
operating income			-72.80M -	-80.66M 10.80%	-82.36M 2.11%	-139.77M 69.70%	-133.41M 4.55%	-162.25M 21.62%	-163.97M 1.06%	-137.77M 15.98%
depreciation and amortization			3.29M -	5.42M 65.03%	7.81M 44.02%	8.01M 2.56%	7.59M 5.19%	6.57M 13.52%	6.08M 7.49%	9.86M 62.26%
total other income expenses net			1.00M -	8.74M 772.65%	-15.50M 277.28%	2.85M 118.37%	3.48M 22.06%	4.95M 42.36%	1.01M 79.66%	9.19M 813.77%
income before tax			-70.69M -	-69.69M 1.41%	-95.02M 36.35%	-136.92M 44.10%	-129.93M 5.11%	-157.30M 21.06%	-162.96M 3.60%	-128.57M 21.10%
income tax expense			892K -	451K 49.44%	497K 10.20%	242K 51.31%	162K 33.06%	791K 388.27%	2.50M 215.68%	-14.26M 671.13%
net income	-12.70M -	-21.59M 69.96%	-71.58M 231.56%	-70.14M 2.01%	-95.51M 36.18%	-137.16M 43.61%	-130.09M 5.16%	-158.09M 21.52%	-165.46M 4.66%	-114.31M 30.91%
weighted average shs out	424.71M -	35.78M 91.57%	70.79M 97.81%	87.94M 24.23%	97.39M 10.75%	104.97M 7.78%	142.46M 35.72%	155.81M 9.36%	161.21M 3.47%	201.07M 24.73%
weighted average shs out dil	424.71M -	35.78M 91.57%	70.79M 97.81%	87.94M 24.23%	97.39M 10.75%	104.97M 7.78%	142.46M 35.72%	155.81M 9.36%	161.21M 3.47%	201.07M 24.73%
eps	-0.03 -	-0.60 1,906.69%	-1.01 68.33%	-0.80 20.79%	-0.98 22.50%	-1.31 33.67%	-0.91 30.53%	-1.01 10.99%	-1.03 1.98%	-0.57 44.66%
epsdiluted	-0.03 -	-0.60 1,906.69%	-1.01 68.33%	-0.80 20.79%	-0.98 22.50%	-1.31 33.67%	-0.91 30.53%	-1.01 10.99%	-1.03 1.98%	-0.57 44.66%

All numbers in USD (except ratios and percentages)